ABDM Microsites Mobile Application for field officers and ABDM Microsites Dashboard launched for effective on-ground implementation and monitoring
Conditional marketing authorization is based on clinically meaningful response rates, duration of response, and safety from the Phase 2 MagnetisMM-3 trial
Sarclisa added to bortezomib, lenalidomide and dexamethasone (VRd) significantly reduced the risk of disease progression or death compared with VRd alone
Collaboration enables Brenntag to serve pharma customers in EMEA with chromatography silica gels
Aster Whitefield will be Aster's 3 rd multi-specialty hospital in Bengaluru and overall 19th hospital in India
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
ELREXFIO’s label contains a boxed warning for cytokine release syndrome and neurologic toxicity
Apollo Transplant program is the first program in India to cross the landmark of 18500 kidney transplants, 4300 liver transplants and 500 pediatric liver transplants
Approval to dramatically change CAR-T therapies landscape
Adding 20,000 liters of installed biologics drug substance manufacturing capacity
Subscribe To Our Newsletter & Stay Updated
